AZALIST TAB
MRP: 1,750
Packaging: 10x10
Pack Type: tablet
Composition:
Azathioprine I.P. 50 mg Excipients q.s. Colour : Titanium Dioxide I.P.
Indication:
Prevent organ rejection after kidney transplantation Treat autoimmune diseases like rheumatoid arthritis, lupus, Crohn’s disease, and ulcerative colitis Manage severe skin conditions like pemphigus and psoriasis
Description:
This tablet combines Bisoprolol Fumarate, a cardioselective beta-blocker, and Dapagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It is primarily used in patients with Type 2 Diabetes Mellitus and/or Heart Failure with Reduced Ejection Fraction (HFrEF). Bisoprolol helps reduce blood pressure and heart rate, while Dapagliflozin lowers blood glucose levels and improves cardiovascular outcomes.
Tags:
- Suppresses abnormal immune response
- Helps prevent rejection in kidney and liver transplants
- Controls symptoms of autoimmune diseases
- Reduces joint pain and inflammation
- Can be steroid-sparing in long-term therapy
Usage Information
Dosage
Usual adult dose: 1–3 mg/kg/day (adjusted by physician). Take after meals to minimize stomach upset. Swallow whole with water. Regular blood tests (CBC, LFT) are required during use.
Side Effects
Dizziness or fatigue Nausea, vomiting Fatigue Low white blood cell count (increased infection risk) Liver enzyme abnormalities Hair loss (rare) Skin rash or hypersensitivity reaction
Contraindications
Hypersensitivity to azathioprine Pregnancy (unless clearly needed) Lactation (passes into breast milk) Severe liver disease Concurrent use with allopurinol without dose adjustment